King Wealth Management Group’s United Therapeutics UTHR Stock Holding History

King Wealth Management Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.2M	Buy	7,749 +3,599	+87%	+$1.86M	0.43%	37
2026 Q2	$2.25M	Hold	4,150	–	–	0.25%	47
2026 Q1	$2.46M	Buy	4,150 +2,650	+177%	+$1.32M	0.31%	45
2025 Q4	$731K	Hold	1,500	–	–	0.09%	84
2025 Q3	$629K	Hold	1,500	–	–	0.08%	90
2025 Q2	$431K	Hold	1,500	–	–	0.06%	106
2025 Q1	$462K	Hold	1,500	–	–	0.07%	96
2024 Q4	$529K	Hold	1,500	–	–	0.08%	88
2024 Q3	$538K	Sell	1,500 -500	-25%	-$169K	0.08%	84
2024 Q2	$637K	Sell	2,000 -3,000	-60%	-$794K	0.11%	75
2024 Q1	$1.15M	Hold	5,000	–	–	0.2%	55
2023 Q4	$1.1M	Hold	5,000	–	–	0.21%	54
2023 Q3	$1.13M	Hold	5,000	–	–	0.24%	51
2023 Q2	$1.1M	Hold	5,000	–	–	0.22%	54
2023 Q1	$1.12M	Hold	5,000	–	–	0.25%	52
2022 Q4	$1.39M	Hold	5,000	–	–	0.33%	43
2022 Q3	$1.05M	Sell	5,000 -1,000	-17%	-$224K	0.27%	49
2022 Q2	$1.41M	Sell	6,000 -3,500	-37%	-$712K	0.34%	46
2022 Q1	$1.7M	Buy	9,500 +2,000	+27%	+$381K	0.33%	45
2021 Q4	$1.62M	Hold	7,500	–	–	0.3%	46
2021 Q3	$1.38M	Hold	7,500	–	–	0.28%	48
2021 Q2	$1.35M	Sell	7,500 -500	-6%	-$95.2K	0.28%	54
2021 Q1	$1.34M	Hold	8,000	–	–	0.3%	54
2020 Q4	$1.21M	Sell	8,000 -1,000	-11%	-$131K	0.28%	56
2020 Q3	$909K	Buy	9,000 +1,000	+13%	+$110K	0.24%	61
2020 Q2	$968K	Buy	8,000 +5,000	+167%	+$563K	0.28%	53
2020 Q1	$284K	Hold	3,000	–	–	0.12%	100
2019 Q4	$264K	Buy	+3,000	New	+$264K	0.07%	121

Other funds holding UTHR

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return

King Wealth Management Group's UTHR Position: Q3 2026 in Review

King Wealth Management Group increased its United Therapeutics (UTHR) stake by 87% in Q3 2026, buying an estimated $1.86M and bringing the position to 7,749 shares worth $4.2M. The position accounts for 0.43% of the portfolio, ranked #37.

King Wealth Management Group first reported a position in UTHR in Q4 2019 and has held it in 28 quarters since. 567 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

King Wealth Management Group held 7,749 shares of United Therapeutics worth $4.2M as of Q3 2026.
King Wealth Management Group bought 3,599 United Therapeutics shares in Q3 2026, an estimated $1.86M.
United Therapeutics made up 0.43% of King Wealth Management Group's portfolio in Q3 2026, its #37 holding.
King Wealth Management Group first reported a position in United Therapeutics in Q4 2019 and has held it in 28 quarters since.
567 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on King Wealth Management Group's 13F filing for Q3 2026, filed 9 Nov 2026.